Cytovia
M&A
STATUS
Corporate
LATEST DEAL TYPE
(Cancelled)
3
FINANCING ROUNDS
Description
Developer of bio-medicines and drugs. The company's bio-medicines and drugs include a patented drug screening technology and discovers and develops small-molecule inhibitors and activators of capsules, enabling the patients to get cured from cancer.
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Drug Discovery
Acquirer
Primary Office
- 6650 Nancy Ridge Drive
- San Diego, CA 92121
- United States
+1 (858) 000-0000
Cytovia Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Cytovia‘s full profile, request access.
Request full access to PitchBookCytovia Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Cytovia‘s full profile, request access.
Request full access to PitchBookCytovia Executive Team (4)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Daniel Teper | Chief Executive Officer |
3 Former Executives
You’re viewing 1 of 4 executives. Get the full list »